ADVENT AD Podcast: Atopic Dermatitis: Understanding Bone Health & Growth in Pediatric Atopic Dermatitis

2026-08-17

In this episode, Dr. Amy Paller and Dr. Lisa Swanson as they delve into the risk of low bone mineral density and impaired growth reported in pediatric atopic dermatitis and observed improvements in growth observed with advanced therapy, especially among children with shorter stature at baseline. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. ·       Disclaimer:o   This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.o   The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program.o   The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits.·       Speaker disclosures:o   Lisa Swanson, MD, FAAD, has served as an investigator for Arcutis, Castle, Organon, and Sun. Dr. Swanson has participated as a speaker for AbbVie, Arcutis, Galderma, Incyte, Johnson & Johnson, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. In addition, she has served as a consultant and advisory board member for AbbVie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Chiesi, Galderma, Incyte, Johnson & Johnson, Leo, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica.o   Amy Paller, MD, MS, has served as an advisor and consultant and has received grant funding from AbbVie, Abeona, Aegerion Pharmaceuticals, Azitra, BioCryst, Boehringer Ingelheim, Bristol Myers Squibb, Castle Creek Biosciences, Catawba, Eli Lilly and Company, Galderma, Gilead, InMed Pharmaceuticals, Janssen, Krystal Biotech, LEO Pharma, Novartis, Regeneron, Sanofi/Genzyme, Seanergy (consultant with honorarium), TWi Biotechnology, and UCB.© 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.MAT-GLB-2600170 – 1.0 – 07/2026  Course Descriptors: MAT-GLB-2604085 – 1.0 – 07/2026  

Número de episodios

28

Último episodio

2026-10-08

¿Donde puedes escuchar?

Apple Podcasts Spotify Podtail Google Podcasts RSS

The latest updates in type 2 inflammatory science, brought to you by leading experts in the field.
The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area.
Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com.
This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals.

©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-GLB-2302644 v2.0 07/2023
MAT-US-2304947 v1.0-P Exp. Date 07/07/2025